BioStem Technologies officer converts awards to 970 shares
After the reported conversion, the chief accounting officer held 69,634 common shares directly.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
BioStem Technologies, Inc. (BSEM) reported that Chief Accounting Officer Michael A. Fortunato converted 970 restricted stock units into 970 common shares on November 9, 2026. His reported direct common-stock holdings following the transaction were 69,634 shares. The report also lists options to buy 200,000 common shares at an exercise price of $1.07 per share, expiring August 16, 2027.
Insider Trade Summary
970 shares exercised/converted
Exercise
2 txns
Insider
FORTUNATO MICHAEL A
Role
Chief Accounting Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units F6, F8 | 970 | $0.00 | $0.00 |
| Exercise | Common Stock | 970 | $0.00 | $0.00 |
| Holding | Options (Right to Buy) F1 | -- | -- | -- |
| Holding | Options (Right to Buy) F2 | -- | -- | -- |
| Holding | Options (Right to Buy) F3 | -- | -- | -- |
| Holding | Options (Right to Buy) F4 | -- | -- | -- |
| Holding | Options (Right to Buy) F5 | -- | -- | -- |
| Holding | Restricted Stock Units F6, F7 | -- | -- | -- |
| Holding | Restricted Stock Units F6, F9 | -- | -- | -- |
Holdings After Transaction:
Restricted Stock Units — 54,579 units, with 48,759 underlying shares of Common Stock (Direct);
Common Stock — 69,634 shares (Direct);
Options (Right to Buy) — 352,468 options (Direct)
Holdings Before and After:
Restricted Stock Units, 55,549 to 54,579 units (Direct);
Common Stock, 68,664 to 69,634 shares (Direct)
Footnotes (9)
- F1. These options are fully vested and exercisable.
- F2. These options vest according to the following schedule: 25% vested on January 4, 2024, the one year anniversary of the grant date, with the remaining options vesting in equal monthly installments over the subsequent three year period.
- F3. These options vest according to the following schedule: 33% vested on May 9, 2026, the one year anniversary of the grant date, with the remaining options vesting in equal quarterly installments over the subsequent two year period.
- F4. These options vest according to the following schedule: 33% vested on October 13, 2026, the one year anniversary of the grant date, with the remaining options vesting in equal quarterly installments over the subsequent two year period.
- F5. These options vest according to the following schedule: 33% will vest on February 11, 2027, the one year anniversary of the grant date, with the remaining options vesting in equal quarterly installments over the subsequent two year period.
- F6. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
- F7. These restricted stock units vest in equal quarterly installments over three years from the grant date (September 15, 2024).
- F8. These restricted stock units vest according to the following schedule: 33% vested on May 9, 2026, the one year anniversary of the grant date, with the remaining units vesting in equal quarterly installments over the subsequent two year period.
- F9. These restricted stock units vest according to the following schedule: 33% will vest on February 11, 2027, the one year anniversary of the grant date, with the remaining units vesting in equal quarterly installments over the subsequent two year period.
Key Figures
Restricted stock units converted: 970 units
Common shares acquired: 970 shares
Direct common shares following transaction: 69,634 shares
+4 more
7 metrics
Restricted stock units converted
970 units
November 9, 2026
Common shares acquired
970 shares
November 9, 2026
Direct common shares following transaction
69,634 shares
Reported after the November 9, 2026 transaction
Options at $1.07 per share
200,000 underlying shares
Expiration date: August 16, 2027
Options at $2.99 per share
100,000 underlying shares
Expiration date: January 4, 2033
Restricted stock units
16,941 units
Direct holding reported November 9, 2026
Restricted stock units
31,818 units
Direct holding reported November 9, 2026
Key Terms
Restricted Stock Units, Options (Right to Buy), vest
3 terms
Restricted Stock Units financial
"Each restricted stock unit represents a contingent right to receive one share"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Options (Right to Buy) financial
"Options (Right to Buy)"
vest financial
"These options vest according to the following schedule"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What option holdings did BSEM Chief Accounting Officer Michael A. Fortunato report?
The reported direct options were 200,000 shares at $1.07, expiring August 16, 2027; 100,000 at $2.99, expiring January 4, 2033; 11,582 and 2,340 at $15.11, expiring May 9 and October 13, 2035; and 38,546 at $5.50, expiring February 11, 2036.
AI-generated analysis. How Rhea-AI works. Not financial advice.
